370 related articles for article (PubMed ID: 17689277)
1. Activation and silencing of matrix metalloproteinases.
Fu X; Parks WC; Heinecke JW
Semin Cell Dev Biol; 2008 Feb; 19(1):2-13. PubMed ID: 17689277
[TBL] [Abstract][Full Text] [Related]
2. Control of matrix metalloproteinase catalytic activity.
Ra HJ; Parks WC
Matrix Biol; 2007 Oct; 26(8):587-96. PubMed ID: 17669641
[TBL] [Abstract][Full Text] [Related]
3. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
[TBL] [Abstract][Full Text] [Related]
4. [Matrix metalloproteinases and their tissue inhibitors].
Trojanek J
Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and Biological Attributes of Matrix Metalloproteinases.
Cui N; Hu M; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
[TBL] [Abstract][Full Text] [Related]
6. Role of matrix metalloproteinases in renal pathophysiologies.
Catania JM; Chen G; Parrish AR
Am J Physiol Renal Physiol; 2007 Mar; 292(3):F905-11. PubMed ID: 17190907
[TBL] [Abstract][Full Text] [Related]
7. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future.
Apte SS; Parks WC
Matrix Biol; 2015; 44-46():1-6. PubMed ID: 25916966
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions.
Varghese S
Front Biosci; 2006 Sep; 11():2949-66. PubMed ID: 16720367
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
Maskos K; Bode W
Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
[TBL] [Abstract][Full Text] [Related]
11. The role of TIMPs in regulation of extracellular matrix proteolysis.
Arpino V; Brock M; Gill SE
Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
[TBL] [Abstract][Full Text] [Related]
12. Extracellular regulation of metalloproteinases.
Yamamoto K; Murphy G; Troeberg L
Matrix Biol; 2015; 44-46():255-63. PubMed ID: 25701651
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
Visse R; Nagase H
Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
[TBL] [Abstract][Full Text] [Related]
14. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
Narula S; Tandon C; Tandon S
Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
Bode W; Maskos K
Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
[TBL] [Abstract][Full Text] [Related]
16. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
Wang X; Khalil RA
Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain.
Dzwonek J; Rylski M; Kaczmarek L
FEBS Lett; 2004 Jun; 567(1):129-35. PubMed ID: 15165905
[TBL] [Abstract][Full Text] [Related]
18. Matrix Metalloproteinases in Kidney Disease: Role in Pathogenesis and Potential as a Therapeutic Target.
Parrish AR
Prog Mol Biol Transl Sci; 2017; 148():31-65. PubMed ID: 28662825
[TBL] [Abstract][Full Text] [Related]
19. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
Briasoulis A; Tousoulis D; Papageorgiou N; Kampoli AM; Androulakis E; Antoniades C; Tsiamis E; Latsios G; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1214-21. PubMed ID: 22519451
[TBL] [Abstract][Full Text] [Related]
20. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
Cells; 2020 May; 9(5):. PubMed ID: 32466129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
